Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+1.01%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$66.1B
AUM Growth
-$1.48B
Cap. Flow
-$395M
Cap. Flow %
-0.6%
Top 10 Hldgs %
10.65%
Holding
3,989
New
456
Increased
1,473
Reduced
1,442
Closed
583

Top Sells

1
AAPL icon
Apple
AAPL
+$549M
2
PLTR icon
Palantir
PLTR
+$549M
3
NFLX icon
Netflix
NFLX
+$378M
4
NVDA icon
NVIDIA
NVDA
+$267M
5
BABA icon
Alibaba
BABA
+$207M

Sector Composition

1 Technology 17.41%
2 Healthcare 14.96%
3 Consumer Discretionary 11.86%
4 Financials 11.03%
5 Industrials 8.48%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NXGL icon
3001
NexGel
NXGL
$19.9M
$243K ﹤0.01%
81,631
-76,700
-48% -$229K
OLMA icon
3002
Olema Pharmaceuticals
OLMA
$549M
$243K ﹤0.01%
64,600
-92,700
-59% -$349K
VEU icon
3003
Vanguard FTSE All-World ex-US ETF
VEU
$49.9B
$243K ﹤0.01%
4,000
-36,600
-90% -$2.22M
AVNS icon
3004
Avanos Medical
AVNS
$576M
$242K ﹤0.01%
+16,900
New +$242K
KIE icon
3005
SPDR S&P Insurance ETF
KIE
$830M
$242K ﹤0.01%
4,000
-43,600
-92% -$2.64M
LIVE icon
3006
Live Ventures
LIVE
$50.3M
$242K ﹤0.01%
31,699
-2,100
-6% -$16K
LSTA icon
3007
Lisata Therapeutics
LSTA
$19.6M
$241K ﹤0.01%
102,722
+1,400
+1% +$3.29K
BV icon
3008
BrightView Holdings
BV
$1.34B
$241K ﹤0.01%
+18,800
New +$241K
KYTX icon
3009
Kyverna Therapeutics
KYTX
$179M
$241K ﹤0.01%
124,958
+80,258
+180% +$155K
DM
3010
DELISTED
Desktop Metal, Inc.
DM
$239K ﹤0.01%
48,762
-1,500
-3% -$7.37K
TNGX icon
3011
Tango Therapeutics
TNGX
$761M
$239K ﹤0.01%
174,500
+153,000
+712% +$210K
EVCM icon
3012
EverCommerce
EVCM
$2.16B
$239K ﹤0.01%
23,700
+1,500
+7% +$15.1K
BODI icon
3013
The Beachbody Company, Inc. Class A Common Stock
BODI
$42.3M
$239K ﹤0.01%
31,864
+400
+1% +$3K
SSY
3014
DELISTED
SunLink Health Systems
SSY
$238K ﹤0.01%
238,278
-200
-0.1% -$200
TSAT icon
3015
Telesat
TSAT
$324M
$237K ﹤0.01%
+12,600
New +$237K
AOA icon
3016
iShares Core 80/20 Aggressive Allocation ETF
AOA
$2.57B
$237K ﹤0.01%
3,100
-3,700
-54% -$283K
HHS icon
3017
Harte-Hanks
HHS
$27.6M
$237K ﹤0.01%
49,284
-22,216
-31% -$107K
BEAM icon
3018
Beam Therapeutics
BEAM
$2.18B
$236K ﹤0.01%
12,107
-10,800
-47% -$211K
FSEA icon
3019
First Seacoast Bancorp
FSEA
$54.3M
$236K ﹤0.01%
20,232
+1,200
+6% +$14K
DSI icon
3020
iShares MSCI KLD 400 Social ETF
DSI
$4.9B
$236K ﹤0.01%
2,300
-12,800
-85% -$1.31M
SGMA
3021
DELISTED
Sigmatron International
SGMA
$235K ﹤0.01%
188,281
-11,664
-6% -$14.6K
GLDG
3022
GoldMining Inc
GLDG
$239M
$235K ﹤0.01%
276,770
+117,163
+73% +$99.6K
RUSHA icon
3023
Rush Enterprises Class A
RUSHA
$4.48B
$235K ﹤0.01%
4,400
-158,000
-97% -$8.44M
TCI icon
3024
Transcontinental Realty Investors
TCI
$406M
$235K ﹤0.01%
8,400
ACHV icon
3025
Achieve Life Sciences
ACHV
$161M
$235K ﹤0.01%
87,886
+26,726
+44% +$71.4K